Resultados de la búsqueda 821-830 of 19167 for Two-phase

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... Stage I-III breast cancer. A Study of Standard ... 2-year progression free survival (PFS) rate as compared to ACNS0122. ... The purpose of this study is to compare ...

  2. Hematología - Ensayos clínicos

    This is a Phase 1b/2 open-label study to evaluate the safety/efficacy of MEDI-551 + MEDI0680 (AMP-514) in participants with relapsed or refractory ...

  3. Cirugía - Ensayos clínicos - Mayo Clinic

    Phase I/​II Study of [225Ac]Ac-PSMA-R2 in PSMA ... Ir a página 22 · Ir a página 33 · Ir a página 44 · Ir a ... Ir a página 22 · Ir a página 33 · Ir a página 44 ...

  4. Cirugía - Ensayos clínicos - Mayo Clinic

    Phase I/​II Study of [225Ac]Ac-PSMA-R2 in PSMA ... Ir a página 22 · Ir a página 33 · Ir a página 44 · Ir a ... Ir a página 22 · Ir a página 33 · Ir a página 44 ...

  5. Oncología (médica) - Ensayos clínicos

    This is a Phase 1b/2 open-label study to evaluate the safety/efficacy of MEDI-551 + MEDI0680 (AMP-514) in participants with relapsed or refractory ...

  6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Phase Ib Study of Axatilimab in Combination with Olaparib in BRCA1/2 and PALB2- Associated Metastatic HER2-negative Breast Cancer. Rochester, Minn. This ...

  7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This is a phase 1b/2 study of the safety and efficacy of MLN0128 in ... 2 negative (ER+/HER2-) advanced or metastatic breast cancer that has progressed ...

  8. Cirugía - Ensayos clínicos - Mayo Clinic

    This is an open label, phase I/II, multi-center study in adult participants with metastatic hormone sensitive prostate cancer (mHSPC) and with metastatic ...

  9. Nefrología e hipertensión - Ensayos clínicos - Mayo Clinic

    ADPKD is a leading cause of end-stage renal disease. ... The purpose is also to investigate and compare safety for these two treatments. ... ADPKD is a leading ...

  10. Radiología - Ensayos clínicos - Mayo Clinic

    This is an open label, phase I/II, multi-center study in adult participants with metastatic hormone sensitive prostate cancer (mHSPC) and with metastatic ...